Myriad discovers and commercializes genetic tests that determine the risk of developing disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where critical genetic insights can significantly improve patient care and lower healthcare costs.
Since 1991, Myriad has invested heavily in educating patients and healthcare professionals about the role genes play in disease. Millions of patients have already benefited from Myriad’s tests that empower individuals with vital genetic insights and enable healthcare providers to better detect, treat and prevent disease.